CAS: | 1322001-35-3 | ||
分子式: | C21H29ClN2O2S | ||
分子量: | 408.99 | ||
中文名称: |
| ||
英文名称: |
|
货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 | ||||||||||||||||||||||||||||||||||||||||||
P927369 | MACKLIN | 2-甲基-N-((2-(吡咯烷-1-基-磺酰基)联苯-4-基甲基)丙-1-胺盐酸盐 | 903元/200mg; | 展开 | |||||||||||||||||||||||||||||||||||||||||||
储存:室温 | |||||||||||||||||||||||||||||||||||||||||||||||
PZ0206 | Sigma-Aldrich | PF-04455242 hydrochloride | ≥98% (HPLC) | 1476.5元/5 MG; 4776.54元/25 MG; | 展开 | ||||||||||||||||||||||||||||||||||||||||||
产品说明 包装 5, 25 mg in glass bottle 生化/生理作用 PF-4455242 is a selective k opioid receptor (KOR) antagonist with 20-fold selectivity for kappa over mu receptors (k Ki = 3 nM, μ Ki =64 nM). PF-4455242 is orally active, has good brain penetration in rats and was able to block the effects of the kappa agonist U50488. Studies indicate that k blockade has afforded antidepressant activity in several animal models. PF-4455242 has been in phase I clinical trials for trial for bipolar depression. 特点和优势 This compound is featured on the Opioid Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here. 其他说明 This compound was developed by Pfizer for Neuroscience research. To learn more about Sigma′s partnership with Pfizer and view other authentic, high-quality Pfizer compounds, visit sigma.com/bsm-pfizer. 法律信息 Sold for research purposes under agreement from Pfizer Inc. 基本信息
产品性质
安全信息
|